Immunoreactivity to Lys63-linked polyubiquitin is a feature of neurodegeneration
Open accessAbstract
The major human neurodegenerative diseases are characterised by ubiquitin-positive intraneuronal inclusions, however the precise nature of the ubiquitin modifications in these structures is unclear. Using a monoclonal antibody specific for Lys63-linked polyubiquitin we have performed the first immunohistochemical analysis of linkage-specific ubiquitination in vivo associated with neurodegeneration. Immunoreactivity was detected within the pathological lesions of Alzheimer's, Huntington's and Parkinson's disease brains, although staining of Lewy bodies in the substantia nigra in Parkinson's disease was rare, indicating a selective involvement of Lys63-linked polyubiquitin in inclusion biogenesis in this disorder. Immunoreactivity was also a feature in neurons of proteasome-depleted mice, suggesting a proteasomal contribution to the degradation of Lys63-linked polyubiquitinated proteins in vivo.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Ubiquitination plays an important role in maintaining a pool of cellular tau under physiological conditions.
“Therefore, ubiquitination plays an important role in maintaining a pool of cellular tau under physiological conditions.”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [165]
Cites
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,659 · see citing works
Anderson, J. P., Walker, D., Goldstein, J. M., de Laat, R., Banducci, K., Caccavello, R. J., Barbour, R., Huang, J., Kling, K., Lee, M., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600933200 · Cited by 1,418 · see citing works
Atypical ubiquitin chains: new molecular signals
Ikeda, F., & Đikić, I. (2008) · EMBO Reports · doi:10.1038/embor.2008.93 · Cited by 829 · see citing works
Lim, K. L., Chew, K. C. M., Tan, J. M. M., Wang, C., Chung, K. K. K., Zhang, Y., Tanaka, Y., Smith, W. W., Engelender, S., Ross, C. A., et al. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4474-04.2005 · Cited by 543 · see citing works
Lowe, J., Blanchard, A., Morrell, K., Lennox, G., Reynolds, L., Billett, M., Landon, M., & Mayer, R. J. (1988) · The Journal of Pathology · doi:10.1002/path.1711550105 · Cited by 539 · see citing works
Self-citationGlobal changes to the ubiquitin system in Huntington's disease
Bennett, E. J., Shaler, T. A., Woodman, B., Ryu, K.-Y., Zaitseva, T. S., Becker, C. H., Bates, G. P., Schulman, H., & Kopito, R. R. (2007) · Nature · doi:10.1038/nature06022 · Cited by 497 · see citing works
Tan, J. M. M., Wong, E. S. P., Kirkpatrick, D. S., Pletniková, O., Ko, H. S., Tay, S.-P., Ho, M. W. L., Troncoso, J. C., Gygi, S. P., Lee, M. K., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm320 · Cited by 444 · see citing works
Kim, H. T., Kim, K. P., Lledı́as, F., Kisselev, A. F., Scaglione, K. M., Skowyra, D., Gygi, S. P., & Goldberg, A. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609659200 · Cited by 438 · see citing works
Inhibition of Proteolysis and Cell Cycle Progression in a Multiubiquitination-Deficient Yeast Mutant
Finley, D. J., Sadis, S., Monia, B. P., Boucher, P., Ecker, D. J., Crooke, S. T., & Chau, V. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.8.5501 · Cited by 374 · see citing works
Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments
Morishima-Kawashima, M., Hasegawa, M., Takio, K., Suzuki, M., Titani, K., & Ihara, Y. (1993) · Neuron · doi:10.1016/0896-6273(93)90063-w · Cited by 332 · see citing works
Bedford, L., Hay, D., Devoy, A., Paine, S., Powe, D. G., Seth, R., Gray, T., Topham, I., Fone, K., Rezvani, N., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2218-08.2008 · Cited by 327 · see citing works
Self-citationInhibition of the ubiquitin-proteasome system in Alzheimer's disease
Lam, Y. A., Pickart, C. M., Alban, A., Landon, M., Jamieson, C. J., Ramage, R., Mayer, R. J., & Layfield, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.170173897 · Cited by 325 · see citing works
Self-citationSequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation
Babu, J. R., Geetha, T., & Wooten, M. W. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03181.x · Cited by 315 · see citing works
Cripps, D., Thomas, S. N., Jeng, Y., Yang, F., Davies, P., & Yang, A. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512786200 · Cited by 312 · see citing works
Lysine 63‐linked polyubiquitin chain may serve as a targeting signal for the 26S proteasome
Saeki, Y., Kudo, T., Sone, T., Kikuchi, Y., Yokosawa, H., Toh‐e, A., & Tanaka, K. (2009) · The EMBO Journal · doi:10.1038/emboj.2008.305 · Cited by 260 · see citing works
Manetto, V., Perry, G. L., Tabaton, M., Mulvihill, P., Fried, V. A., Smith, H. T., Gambetti, P., & AUTILIO‐GAMBETTI, L. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4501 · Cited by 199 · see citing works
Wang, H., Matsuzawa, A., Brown, S. A., Zhou, J., Guy, C. S., Tseng, P., Forbes, K., Nicholson, T. P., Sheppard, P. W., Häcker, H., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810461105 · Cited by 67 · see citing works
Self-citationLiu, C., Fei, E., Jia, N., Wang, H., Tao, R.-S., Iwata, A., Nukina, N., Zhou, J., & Wang, G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700422200 · Cited by 45 · see citing works
Thorpe, J. R., Mosaheb, S., Hashemzadeh‐Bonehi, L., Cairns, N. J., Kay, J. E., Morley, S., & Rulten, S. L. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.07.008 · Cited by 44 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Guo, T., Zhang, D., Zeng, Y., Huang, T. Y., Xu, H., & Zhao, Y. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00391-7 · Cited by 994 · see citing works
Ubiquitin-like protein conjugation and the ubiquitin–proteasome system as drug targets
Bedford, L., Lowe, J., Dick, L. R., Mayer, R. J., & Brownell, J. E. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3321 · Cited by 563 · see citing works
Self-citationTau degradation: The ubiquitin–proteasome system versus the autophagy-lysosome system
Lee, M. J., Lee, J. H., & Rubinsztein, D. C. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.03.001 · Cited by 364 · see citing works
Assembly, structure, and function of the 26S proteasome
Bedford, L., Paine, S., Sheppard, P. W., Mayer, R. J., & Roelofs, J. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.03.007 · Cited by 252 · see citing works
Self-citationVersatile Roles of K63-Linked Ubiquitin Chains in Trafficking
Erpapazoglou, Z., Walker, O., & Haguenauer‐Tsapis, R. (2014) · Cells · doi:10.3390/cells3041027 · Cited by 203 · see citing works
The Ubiquitin-Proteasome System and the Autophagic-Lysosomal System in Alzheimer Disease
Ihara, Y., Morishima-Kawashima, M., & Nixon, R. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006361 · Cited by 190 · see citing works
Dammer, E. B., Na, C. H., Xu, P., Seyfried, N. T., Duong, D. M., Cheng, D., Gearing, M., Rees, H. D., Lah, J. J., Levey, A. I., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.149633 · Cited by 182 · see citing works
Comparative Proteomic Analysis Identifies a Role for SUMO in Protein Quality Control
Tatham, M. H., Matić, I., Mann, M., & Hay, R. T. (2011) · Science Signaling · doi:10.1126/scisignal.2001484 · Cited by 175 · see citing works
Shen, W.-C., Li, H.-Y., Chen, G., Chern, Y., & Tu, P. (2014) · Autophagy · doi:10.4161/auto.36098 · Cited by 168 · see citing works
The ubiquitin proteasome system in neurodegenerative diseases: Culprit, accomplice or victim?
Dennissen, F. J. A., Kholod, N., & van Leeuwen, F. W. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.01.003 · Cited by 124 · see citing works
Wang, P., Joberty, G., Buist, A., Vanoosthuyse, A., Stancu, I., Vasconcelos, B., Pierrot, N., Faelth-Savitski, M., Kienlen‐Campard, P., Octave, J., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1663-9 · Cited by 118 · see citing works
Ubiquitin signaling in neurodegenerative diseases: an autophagy and proteasome perspective
Guerroué, F. L., & Youle, R. J. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00667-x · Cited by 101 · see citing works
Role of ubiquitin–proteasome-mediated proteolysis in nervous system disease
Hegde, A. N., & Upadhya, S. C. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.07.006 · Cited by 96 · see citing works
K63-linked ubiquitination and neurodegeneration
Lim, K., & Lim, G. G. Y. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.08.001 · Cited by 88 · see citing works
Tauopathies: Deciphering Disease Mechanisms to Develop Effective Therapies
Silva, M. C., & Haggarty, S. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238948 · Cited by 87 · see citing works
Moscat, J., Díaz-Meco, M. T., & Wooten, M. W. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.119 · Cited by 81 · see citing works
Role of Post‐translational Modifications in Alzheimer's Disease
Ramesh, M., Gopinath, P., & Govindaraju, T. (2019) · ChemBioChem · doi:10.1002/cbic.201900573 · Cited by 68 · see citing works
Puangmalai, N., Sengupta, U., Bhatt, N., Gaikwad, S., Montalbano, M., Bhuyan, A., Garcia, S., McAllen, S., Sonawane, M., Jerez, C., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101766 · Cited by 68 · see citing works
Degradation or aggregation: the ramifications of post-translational modifications on tau
Park, S., Lee, J. H., Jeon, J. H., & Lee, M. J. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.6.077 · Cited by 69 · see citing works
van Tijn, P., Dennissen, F. J. A., Gentier, R. J. G., Hobo, B., Hermes, D., Steinbusch, H. W. M., Van Leeuwen, F. W., & Fischer, D. F. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.07.007 · Cited by 39 · see citing works
Rogers, N. K., Paine, S., Bedford, L. E., & Layfield, R. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01063.x · Cited by 33 · see citing works
Self-citationProteasome Inhibition Promotes Parkin-Ubc13 Interaction and Lysine 63-Linked Ubiquitination
Lim, G. G. Y., Chew, K. C. M., Ng, X., Basil, A. H., Sim, R. W. X., Tan, J. M. M., Chai, C., & Lim, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073235 · Cited by 28 · see citing works
Diverse polyubiquitin chains accumulate following 26S proteasomal dysfunction in mammalian neurones
Bedford, L., Layfield, R., Mayer, R. J., Peng, J., & Xu, P. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2010.12.064 · Cited by 27 · see citing works
Self-citationNakayama, Y., Sakamoto, S., Tsuji, K., Ayaki, T., Tokunaga, F., & Ito, H. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.03.017 · Cited by 24 · see citing works
Dangerous Liaisons: Tau Interaction with Muscarinic Receptors
Wysocka, A., Pałasz, E., Steczkowska, M., & Niewiadomska, G. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200424134311 · Cited by 23 · see citing works
Altered Proteostasis in Neurodegenerative Tauopathies
Papanikolopoulou, K., & Skoulakis, E. M. C. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38266-7_7 · Cited by 21 · see citing works
Suppressing UBE2N ameliorates Alzheimer's disease pathology through the clearance of amyloid beta
Zhang, C., Jia, Q., Zhu, L., Hou, J., Wang, X., Li, D., Zhang, J., Zhang, Y., Su, Y., Tu, Z., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14122 · Cited by 19 · see citing works
Misframed Proteins and Neurodegeneration: A Novel View on Alzheimer’s and Parkinson’s Diseases
Dennissen, F. J. A., Kholod, N., Steinbusch, H. W. M., & van Leeuwen, F. W. (2010) · Neurodegenerative Diseases · doi:10.1159/000285510 · Cited by 21 · see citing works
Role of frameshift ubiquitin B protein in Alzheimer's disease
Chen, X., & Petranović, D. (2016) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1340 · Cited by 14 · see citing works
Rezvani, N., Elkharaz, J., Lawler, K., Mee, M., Mayer, R. J., & Bedford, L. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.05.070 · Cited by 8 · see citing works
Self-citationLenzi, P., Lazzeri, G., Ferrucci, M., Scotto, M., Frati, A., Puglisi‐Allegra, S., Busceti, C. L., & Fornai, F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073929 · Cited by 7 · see citing works
The Ubiquitin Script: writing protein fates in chains
Gupta, D., & Maddika, S. (2025) · Essays in Biochemistry · doi:10.1042/ebc20253031 · Cited by 3 · see citing works
Post-translational modifications as a regulatory code for tau function in health and disease
Nordbeck, A. J., Sharma, B., Garcia, C. A., & Tseng, J. (2026) · Frontiers in Dementia · doi:10.3389/frdem.2026.1834737 · Cited by 3 · see citing works
Gotmanova, N. N., Bobik, T. V., Kriachkov, V. A., Ezhov, A. A., & Bacheva, A. V. (2025) · Biochimie · doi:10.1016/j.biochi.2025.10.014 · Cited by 1 · see citing works
Gotmanova, N. N., & Bacheva, A. V. (2024) · Moscow University Chemistry Bulletin · doi:10.3103/s0027131424700160 · Cited by 1 · see citing works
Gotmanova, N. N., Bobik, T. V., Ezhov, A. A., Valyaeva, A. A., Zvereva, M. I., Rubtsova, M. P., & Bacheva, A. V. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.15.699723 · Cited by 1 · see citing works
Figueiredo, L. S. (2015) · Americanae (AECID Library)
UBB+1, an important switch in the onset of Alzheimer’s disease
Gentier, R. J. G. (2015) · doi:10.26481/dis.20151105rg
Silva, G. M., Wei, W., Manohar, S., & Vogel, C. (2015) · Neuromethods · doi:10.1007/7657_2015_95
MARINESCO BODIES: INTRANUCLEAR INCLUSION-BODIESOF DOPAMINERGIC NEURONS
Grigor’ev, I. P., & Korzhevsky, D. E. (2015) · Medical academic journal · doi:10.17816/maj15228-34
Gotmanova, N. N., & Bacheva, A. V. (2024) · Lomonosov chemistry journal · doi:10.55959/msu0579-9384-2-2024-65-3-228-234
- Authors
- Paine, S., Bedford, L., Thorpe, J. R., Mayer, R. J., Cavey, J. R., Bajaj, N., Sheppard, P. W., Lowe, J., & Layfield, R.
- Affiliations
- University of Nottingham (GB)
- University of Sussex (GB)
- Queen's Medical Centre (GB)
- Corresponding author
- Paine, Simon
- Venue
- Neuroscience Letters
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 460
- Issue
- 3
- Pages
- 205-208
- ISSN
- 0304-3940 (ISSN-L)
- OpenAlex
- W2084252314
- Cited by
- 41
- References
- 19
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 4 · 2022: 1 · 2020: 5 · 2019: 2 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 4 · 2014: 2 · 2013: 2 · 2012: 4
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- Locations
- Neuroscience Letters (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- Parkinson's UK (F-0702, G-4055)
- Pathological Society of Great Britain and Ireland
- Hong Kong Polytechnic University
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Keywords
- neurodegeneration, ubiquitin modification, intraneuronal inclusions, Alzheimer's disease, Huntington's disease, Parkinson's disease, Lewy bodies, proteasome
- MeSH terms
- Alzheimer Disease, Animals, Brain, Humans, Huntington Disease, Immunohistochemistry, Lysine, Neurons, Parkinson Disease, Lewy Bodies, Neurodegenerative Diseases, Polyubiquitin, Proteasome Endopeptidase Complex, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review